logo
Share SHARE
FONT-SIZE Plus   Neg

Monsanto Posts Higher Q2 Profit; Ups FY12 EPS View - Quick Facts

Monsanto Co. (MON) posted an improvement in its second-quarter net income attributable to the company to $1.21 billion from year-ago quarter's $1.02 billion, with quarterly earnings per share growing to $2.24 from $1.88 last year, helped by the strong performance of the seeds and traits business and the timing of an early U.S. season.

Earnings per share from ongoing business for the recent quarter were $2.28, higher than $1.87 in the comparable period. On average, 20 analysts polled by Thomson Reuters expected earnings per share of $2.12 for the quarter. Analysts' estimates typically exclude one-time items.

Net sales totaled $4.75 billion compared with $4.13 billion in the previous year, while 13 analysts estimated revenues of $4.53 billion for the quarter.

For fiscal 2012, the company currently sees earnings per share of $3.45 - $3.50 on a reported basis and $3.49 - $3.54 on an ongoing basis. Previously, the company estimated to achieve $3.39 - $3.44 of ongoing and as-reported earnings per share for fiscal 2012. Twenty-two analysts project earnings of $3.51 per share for the full year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amazon.com Inc. is working on developing a pair of smart glasses that would allow to summon and interact with virtual assistant Alexa while wearing the device, the Financial Times reported, citing people familiar with the plans. The glasses, which would be required to be connected wirelessly to a smartphone to work, is reportedly designed to look like a regular pair of spectacles. Employees at Bombardier Inc.'s aerospace plant in Toronto plan to walk out of the facility on Wednesday morning. The move is an attempt to put pressure on Boeing Co. to drop a trade complaint against the Canadian plane and train maker. The Baltimore Ravens, a professional American football team, postponed its "DNA Day" event just hours before this season's home opener last Sunday. Orig3n Inc., a Boston-based biotech company sponsoring the event, said in a statement that it is "working to address questions from officials from the state of Maryland."
comments powered by Disqus
Follow RTT